EBR Systems reports Q4 2025 preliminary rev ~$900K; WiSE implants double QoQ, clinical studies advance

EBR Systems, Inc.

2025-FY EPS reported -$0.12 revenue$1,617,000

Preliminary Q4 revenue $870K-$935K; FY2025 revenue $1,552K-$1,617K (unaudited, subject to audit adjustments).
Commercial WiSE implants doubled QoQ to 18 in Q4, reaching 30 total for the year; 9 new purchase agreements signed.
WiSE-UP post-approval study enrolled 4 patients; TLC-AU feasibility study enrolled first patient in Australia.
11 additional physicians trained in Q4, bringing total trained to 33 across 21 centers.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.